Pharma Nord
Pharma Nord is a Denmark-founded (1981) manufacturer of preventive dietary supplements and herbal remedies, produced to pharmaceutical-grade GMP standards and sold directly to UK consumers, healthcare practitioners, hospitals, pharmacies, and health food shops under brand variants including Bio-Vitamin D3, Bio-Quinone Q10, Bio-Magnesium, and Bio-Marine Plus.
- Company typePrivate
- Founded1981
- HeadquartersMorpeth, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What Pharma Nord does
Pharma Nord is a privately held, Denmark-founded manufacturer of preventive dietary supplements and herbal remedies, established in 1981 by Eli Wallin and Sven Moesgaard and structured today as a parent in Vejle, Denmark with country-specific subsidiaries including Pharma Nord UK Limited (incorporated 1988, registered office in Morpeth, Northumberland). The portfolio spans vitamins (Bio-Vitamin D3 in cold-pressed olive-oil 'pearl' capsules, Bio-C-Vitamin, Bio-E-Vitamin), minerals (Bio-Magnesium, Bio-Selenium+Zinc — the foundational product from 1981), omega-3 (Bio-Marine Plus in free-fatty-acid form), and coenzyme Q10 (Bio-Quinone Q10 Gold and a vegan Q10 Phyto variant). Core technology differentiation rests on pharmaceutical-grade manufacturing under GMP at a single Vojens, Denmark facility; 32 in-house quality control checks; a patented Q10 oil-matrix dissolution process (European Patent EP 3 190 898 B1) that drives documented bioavailability versus commodity Q10; Phytocaps plant-based softgel IP for vegan/halal/kosok compliance; and blister packaging to shield actives from atmospheric exposure. Roughly 85% of SKUs are registered as medicines in at least one country, materially raising the regulatory bar versus food-grade competitors, and the company maintains a research database of 9,000 studies with 200+ company-conducted publications and 300+ clinical studies using its products, including Coronavit (Queen Mary University of London, 5,000+ participants on Bio-Vitamin D3) and KiSel-10 (Karolinska/Linköping, 53% reduction in cardiovascular mortality for Bio-Quinone Q10 plus SelenoPrecise).
Revenue is generated through a multi-channel model: direct-to-consumer e-commerce via pharmanord.co.uk (unit pricing with a £2.95 delivery threshold under £15, free Royal Mail shipping over £15, an Autoship subscription tier with a discount, and a rewards programme where points collected from on-pack codes redeem against free product); a B2B Practitioner Programme giving healthcare professionals CPD-certified webinars/in-person seminars, a research database, practitioner-rate pricing, and a Practitioner Recommendation Scheme; and physical distribution into UK hospitals (including a 20,000IU Bio-Vitamin D3 SKU), pharmacies, and health food shops. Customer segments span general preventative-health consumers, the elderly, pregnant and breastfeeding mothers, UK residents with limited sunlight exposure, statin users, and healthcare practitioners. The global footprint covers 25+ countries via local websites spanning Europe, Asia (China, Thailand, Vietnam), and the United States, with 50+ offices worldwide; the UK arm cannot ship internationally post-Brexit, so each geography effectively operates as a domestic sub-business.
Pharma Nord firmographics
Firmographics- Name
- Pharma Nord
- Legal name
- Pharma Nord UK Limited
- Website
- https://pharmanord.co.uk
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pharma Nord is a Denmark-founded (1981) manufacturer of preventive dietary supplements and herbal remedies, produced to pharmaceutical-grade GMP standards and sold directly to UK consumers, healthcare practitioners, hospitals, pharmacies, and health food shops under brand variants including Bio-Vitamin D3, Bio-Quinone Q10, Bio-Magnesium, and Bio-Marine Plus.
- Ownership category
- akta.pro rank
Pharma Nord industry classification
Industry- Product category
- Dietary Supplements
- NAICS
- Food (Health) Supplement Retailers (456191)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Vitamins & Minerals (Single Nutrients) (CRADAGAB)
- akta.pro secondary industries
- Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE), Herbal & Botanical Supplements (CRADAGAD), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK), Health, Wellness & Pharmacy Online Retailers (CRAFADAG)
Keywords
Where Pharma Nord is headquartered
LocationHeadquarters
- HQ city
- Morpeth
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Pharma Nord business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Direct E-commerce Sales: Direct-to-consumer online sales through pharmanord.co.uk website. Customers purchase individual products at listed prices with options for standard delivery or Autoship subscription.
- Rewards Programme: Customers earn points from purchasing products which can be redeemed for free products in the Rewards Programme shop. Points are earned by registering codes from product cards.
- Practitioner Programme Sales: Healthcare practitioners purchase products at practitioner rates through dedicated programme. Includes access to research database, CPD training, and referral scheme.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard UK delivery |
| Subscription | Monthly | Autoship Subscription |
| Subscription | Monthly | Rewards Programme |
| Subscription | Pay-as-you-go | Practitioner Rates |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels9 records
Pharma Nord product offering
Product offeringCore offering
Pharma Nord manufactures and sells a portfolio of preventive dietary supplements and herbal remedies including vitamins (Bio-Vitamin D3, Bio-C-Vitamin, Bio-E-Vitamin), minerals (Bio-Magnesium, Bio-Selenium+Zinc), omega-3 fatty acids (Bio-Marine Plus), and coenzyme Q10 (Bio-Quinone Q10 Gold and Vegan). Products are produced to pharmaceutical-grade standards with documented bioavailability, are sold direct to consumers via the pharmanord.co.uk e-commerce site (with Autoship subscription and Rewards Programme) and supplied to healthcare practitioners, pharmacies, health food shops, and hospitals across the UK.
Product overview
Pharma Nord is a European manufacturer of preventive dietary supplements and herbal remedies founded in 1981. The company operates as a multi-product portfolio under a unified quality philosophy of pharmaceutical-grade manufacturing standards and high bioavailability. The core product range centres on vitamins (Bio-Vitamin D3, Bio-C-Vitamin, Bio-E-Vitamin), minerals (Bio-Magnesium, Bio-Selenium+Zinc), omega-3 fatty acids (Bio-Marine Plus), and coenzyme Q10 (Bio-Quinone Q10 Gold and its vegan variant). Products are sold through both direct-to-consumer e-commerce and a Practitioner Programme offering CPD education, research access, and practitioner-only products. A Rewards Programme provides loyalty points on product purchases. All products share the same manufacturing philosophy: pharmaceutical-grade quality, documented bioavailability through clinical research, and blister packaging for stability.
Differentiator
Problem solved
Functional benefit
Brands
- Bio-Vitamin D3: Vitamin D3 supplement dissolved in cold-pressed olive oil, manufactured to pharmaceutical standards; available in multiple strengths (400IU to 5000IU). Chosen for the Coronavit clinical trial at Queen Mary University of London.
- Bio-Quinone Q10 / Q10 Phyto (Vegan)
- Bio-Marine Plus
- Bio-Magnesium
- Bio-Selenium+Zinc
Products and services
- Bio-Vitamin D3 (D-Pearls) Vitamin D3 supplement dissolved in cold-pressed olive oil, manufactured to pharmaceutical standards. Available in multiple strengths (400IU to 5000IU) in easy-to-swallow gelatin pearl capsules, and selected for the Queen Mary University of London Coronavit clinical trial due to documented bioavailability and effectiveness in raising blood vitamin D levels.
- Bio-Marine Plus Omega-3 fish oil supplement containing EPA and DHA in free fatty acid form for direct absorption without normal digestive breakdown. Each capsule supplies 500mg fish oil (185mg EPA, 115mg DHA) plus folic acid and vitamin B12, supporting normal heart, brain, and visual function.
- Bio-Magnesium Magnesium supplement formulated for high absorption and documented in a double-blind, placebo-controlled study that showed a six-fold increase in blood magnesium levels after eight weeks of daily supplementation, supporting normal muscle function, the nervous system, and energy metabolism.
- Bio-Quinone Q10 Gold Ubiquinone CoQ10 supplement in 100mg capsules, the reference product for the International Coenzyme Q10 Association. Manufactured using a patented heating process (EP 3 190 898 B1) that dissolves Q10 crystals at body temperature for superior bioavailability, and used in the KiSel-10 and Q-SYMBIO heart-health clinical trials.
- Bio-Quinone Q10 Vegan (Q10 Phyto) Vegan-friendly coenzyme Q10 supplement using proprietary 100% plant-based Phytocaps softgel technology. Contains natural ubiquinone identical to the body's own CoQ10, documented in 78 human scientific studies, and is compliant with vegetarian, vegan, halal, and kosher diets.
- Bio-E-Vitamin Vitamin E supplement providing 430IU (290mg) of d-alpha-tocopherol per capsule. Manufactured to pharmaceutical standards with a formulation designed to withstand stomach acidity for optimum absorption, providing antioxidant protection for cell membranes from oxidative stress.
- Bio-C-Vitamin Vitamin C supplement providing 750mg per tablet (equivalent to 1.5kg of oranges) using the non-acidic calcium ascorbate form that is gentle on the stomach lining. Contributes to normal immune function, collagen formation, and the reduction of tiredness and fatigue.
- Bio-Selenium+Zinc Selenium and zinc combination supplement combining both trace elements with documented bioavailability. The original cornerstone product of Pharma Nord's range, first developed in 1981 from a selenium product imported from England.
Quantifiable outcome
- 53% decreased risk of dying from cardiovascular disease in KiSel-10 trial with Bio-Quinone Q10 and SelenoPrecise supplementation
- +3 more outcomes
Companies that use Pharma Nord
Customer profileNamed customers3 records
Segments7 records
Ideal customer profiles2 records
Pharma Nord technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration11 records
Feature5 records
Pharma Nord partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered flagship, core and minor.
- Queen Mary University of LondonflagshipPharma Nord's Bio-Vitamin D3 was selected for the prestigious Coronavit clinical trial led by Queen Mary University of London. The trial studies the effects of vitamin D supplementation on the immune system and protection against COVID-19 and other respiratory infections, involving over 5,000 participants for six months.
- Oslo UniversitycoreConducted clinical study on vitamin D and muscle strength using Pharma Nord's Bio-Vitamin D3, demonstrating significant increases in vitamin D blood levels.
- University of SurreycoreResearchers from University of Surrey conducted study showing vitamin D3 is twice as effective as D2, potentially influencing government guidelines.
- University of SouthamptoncoreCollaborated on review published in Nutrition Research Reviews showing that 76% of people globally may not be meeting recommended omega-3 fatty acid intakes.
- Norwegian ResearchersminorNorwegian scientists conducted study on vitamin D and well-being of school pupils using Bio-Vitamin D3, showing significant increases in vitamin D blood levels.
- University Hospital in LinkopingflagshipSwedish researchers from University Hospital in Linkoping and Karolinska Institute conducted the KiSel-10 study showing 53% reduced cardiovascular mortality with Bio-Quinone Q10 and SelenoPrecise supplementation over 5 years in 443 elderly participants.
- Karolinska InstituteflagshipWorld-renowned Swedish research institution collaborating on KiSel-10 study demonstrating cardiovascular benefits of Pharma Nord's Q10 and selenium supplements.
Scale indicators10 records
Recent moves7 records
Expansion highlights5 records
Pharma Nord competitors and assessment
Company assessmentDirect peers
- BetterYou: UK-based premium supplement brand specializing in vitamin D and magnesium delivery formats with strong DTC and pharmacy presence, competing in the same clinical-evidence-led positioning as Pharma Nord.
- Solgar: Premium global vitamin and mineral supplement brand manufactured to high quality standards, with overlapping product categories (vitamin D, magnesium, omega-3, multivitamins) and similar pharmacy and health food shop distribution channels.
- Vitabiotics: UK-based vitamin and supplement manufacturer with a comparable premium positioning and similar multi-channel retail and pharmacy distribution. Closest like-for-like UK competitor to Pharma Nord's product range and quality philosophy.
- BioCare: UK practitioner-focused supplement brand with a strong B2B healthcare professional programme and comparable evidence-led positioning, directly competing for the same practitioner recommendation channel as Pharma Nord.
- Life Extension: Premium US supplement brand combining clinical research-backed formulations with a practitioner-style loyalty programme, overlapping Pharma Nord's evidence-led positioning in cardiovascular, Q10, and vitamin D categories.
- Cytoplan: UK-based wholefood and food-state supplement manufacturer with a practitioner-focused GTM, directly comparable to Pharma Nord's clinical, evidence-driven approach and B2B healthcare professional channel.
Emerging players
- Thorne HealthTech: US-based premium supplement company built around practitioner recommendations and clinical-grade formulation; directly comparable GTM model to Pharma Nord's Practitioner Programme with similar science-led differentiation.
Regional players
- Wassen: UK-based premium supplement manufacturer specializing in magnesium and mineral formulations with comparable pharmacy distribution and clinical-study-backed claims, focused primarily on the UK market.
Broad incumbents
- NOW Foods: One of the largest global supplement manufacturers offering an extensive vitamins, minerals, and specialty supplements portfolio with comparable ingredient categories though differentiated by mass-market pricing rather than pharmaceutical-grade positioning.
- Holland & Barrett: UK's largest health food and supplement retailer with extensive own-brand ranges competing at retail alongside Pharma Nord's products, representing both a channel partner and a competitive threat in mass-market supplement categories.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Pharma Nord social profiles
Digital presencePharma Nord compliance and trust
Trust signalCompliance4 records
Pharma Nord financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharma Nord leadership team
Management profileNumber of profiles
Profiles4 records
Pharma Nord funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharma Nord M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharma Nord
What does Pharma Nord do?
Pharma Nord manufactures and sells a portfolio of preventive dietary supplements and herbal remedies including vitamins (Bio-Vitamin D3, Bio-C-Vitamin, Bio-E-Vitamin), minerals (Bio-Magnesium, Bio-Selenium+Zinc), omega-3 fatty acids (Bio-Marine Plus), and coenzyme Q10 (Bio-Quinone Q10 Gold and Vegan). Products are produced to pharmaceutical-grade standards with documented bioavailability, are sold direct to consumers via the pharmanord.co.uk e-commerce site (with Autoship subscription and Rewards Programme) and supplied to healthcare practitioners, pharmacies, health food shops, and hospitals across the UK.
Is Pharma Nord a public or private company?
Pharma Nord is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Pharma Nord founded?
Pharma Nord was founded in 1981. It employs 11 to 50 people.
Where is Pharma Nord based?
Pharma Nord is headquartered in Morpeth, United Kingdom, in the Europe region.
How does Pharma Nord make money?
Three revenue lines are on record. Direct E-commerce Sales are the primary driver. The others are rewards Programme and practitioner Programme Sales.
Who are Pharma Nord's main competitors?
Direct peers on record are BetterYou, Solgar, Vitabiotics, BioCare, Life Extension and Cytoplan. Thorne HealthTech is listed as an emerging player. Wassen is listed as a regional player. Broad incumbents are NOW Foods and Holland & Barrett.
Does Pharma Nord have an API?
No public API is recorded for Pharma Nord.
What industry is Pharma Nord in?
Pharma Nord's product category is Dietary Supplements. Its primary akta.pro industry code is CRADAGAB, Vitamins & Minerals (Single Nutrients), with a secondary code of CRADAGAE, Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity). Its NAICS code is 456191 and its SIC code is 2833.